Table 1 Patient, tumor and treatment characteristics of the study
From: Actual long-term survival after resection of stage III soft tissue sarcoma
Long-term survivors (n = 61) | Short-term survivors (n = 36) | P-value | |
|---|---|---|---|
Patient characteristics | |||
Age (years) | 48 (13–82) | 59.5 (19–83) | n.s. |
Sex (male) | 32 (52.5%) | 22 (61.1%) | n.s. |
ASA score | 0.006 | ||
I | 38 (62.3%) | 11 (30.6%) | |
II | 21 (34.4%) | 23 (63.9%) | |
III | 2 (3.3%) | 2 (5.6%) | |
Tumor characteristics | |||
Location (extremity) | 50 (82.0%) | 28 (77.8%) | n.s. |
Initial presentation | |||
Unplanned excision | 5 (8.2%) | 1 (2.8%) | n.s. |
Size | |||
> 10 cm | 22 (36.1%) | 21 (58.3%) | 0.037 |
FNCLCC Grade | |||
3 | 29 (47.5%) | 26 (72.2%) | 0.021 |
Depth | |||
Superficial | 5 (8.2%) | 1 (2.8%) | n.s. |
Histological subtypes | |||
Leiomyosarcoma | 3 (4.9%) | 7 (19.4%) | 0.036 |
Treatment characteristics | |||
Surgical | |||
Marginal | 9 (14.8%) | 9 (25%) | n.s. |
Microscopic margin | |||
R1 | 3 (4.9%) | 6 (16.7%) | 0.024 |
Administration of adjuvant chemotherapy | 18 (29.5%) | 13 (36.1%) | n.s. |
Administration of adjuvant radiotherapy | 55 (90.2%) | 21 (58.3%) | 0.001 |